ArticleNPJ breast cancer2025

Prognostic impact of tumor-infiltrating lymphocytes in HER2+ metastatic breast cancer receiving first-line treatment.

Beatrice Taurelli Salimbeni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.